log in
Print | Back


Jonathan S. Feld

Jonathan S. Feld


Illinois, U.S.A.

tel: 312-627-5680
Send an Email

Local Time: Fri. 02:04


Jonathan S. Feld is the Leader of the Government Investigations and Corporate Compliance Team. He is located in Dykema’s Chicago office as well as the Firm’s Washington, D.C. office. 

Mr. Feld’s practice focuses on complex civil and criminal matters, including health care, financial antitrust and antibribery actions. He represents companies, directors and officers in investigations and enforcement actions by the U.S. Department of Justice (DOJ), Securities and Exchange Commission (SEC), the Food and Drug Administration (FDA) and other regulatory agencies. Mr. Feld advises corporations, boards of directors and board committees regarding internal investigations, corporate compliance programs and corporate governance issues, including the Foreign Corrupt Practices Act (FCPA) and data privacy.

Mr. Feld's work encompasses False Claims Act litigation in a variety of industries including health care and consumer finance. He also represents parties in class actions, arbitrations, and commercial litigation.

Mr. Feld served at the DOJ as an Associate Deputy Attorney General. In that role, he oversaw prosecutions from U.S. Attorney's offices nationwide involving a broad array of cases from financial institution fraud to securities matters to environmental prosecutions. He was an Assistant U.S. Attorney for the District of New Jersey, where he concentrated on financial and securities prosecutions and other complex white collar criminal matters. He twice received DOJ Special Achievement awards.

Mr. Feld served as Assistant Special Counsel to the Select Commission established by the State of Rhode Island to investigate the collapse of its multibillion dollar privately-insured financial institution system. In addition, he served as an Associate Independent Counsel for the investigation of the U.S. Department of Housing and Urban Development under the direction of the Hon. Arlin Adams.

Mr. Feld serves on the Board of Editors for Business Crimes Bulletin, a monthly publication about corporate compliance and investigations.

Bar Admissions



District of Columbia

New York


Boston University School of Law, J.D.
  • Law Review
Harvard University, M.C.R.P. Reed College, B.A.
  • Phi Beta Kappa
Areas of Practice
Professional Career

Significant Accomplishments

Representation of hospitals in a multimillion False Claims Act settlements.
Representation of a regulatory director in a criminal FDA prosecution including an off-label marketing violation.
Representation of senior officer of an internet company in securities prosecution.
Representation of physicians in antikickback investigations.
Representation of a multinational foreign company in an antitrust investigation and class action litigation.
Representation of manufacturing, healthcare, technology and financial services companies in internal investigations

Department of Justice Announces Strike Force to Combat Antitrust Crimes in Government Procurements
Dykema, December 2019

On November 5, 2019, the U.S. Department of Justice (DOJ) Antitrust Division announced the establishment of a Procurement Collusion Strike Force (PCSF) to deter, detect, investigate, and prosecute criminal schemes that undermine the integrity of the government procurement process. One of the highlights of the PCSF is to reprioritize prosecutions of cartel conduct after a several-year decline...

The Shift From DOJ Enforcement to Administrative Review for HUD False Claims Act Violations
Dykema, November 2019

The False Claims Act (“FCA”) is one of the most powerful anti-fraud weapons available to the U.S. Department of Justice (“DOJ”). It permits treble damages and makes penalties available for each false claim the defendant submitted to a federal payor. The DOJ effectively deployed the FCA against mortgage lenders in the aftermath of the sub-prime lending crisis to obtain, in some cases, billion-dollar settlements...

Eleventh Circuit Rejects Expert Challenge to Clinical Judgment Decision in Hospice False Claims Act Litigation
Dykema, September 2019

On September 9, 2019, the U.S. Court of Appeals for the Eleventh Circuit issued an important decision for health care providers, especially those in the hospice industry. In U.S. v. AseraCare, Inc.,No.16-13004, Slip. Op. (11thCir. September 9, 2019), the Court held that a “reasonable disagreement between medical experts” about prognosis for a terminally ill patient, without more, cannot establish falsity. Slip. Op. at 3...

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2019